Growing community of inventors

Ottawa, Canada

Eric LaCasse

Average Co-Inventor Count = 3.46

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 30

Eric LaCasse ↔ Daniel McManus (4 patents)Eric LaCasse ↔ Jon P Durkin (3 patents)Eric LaCasse ↔ Robert G Korneluk (2 patents)Eric LaCasse ↔ Stephen Baird (2 patents)Eric LaCasse ↔ Martin Holcik (2 patents)Eric LaCasse ↔ Sean Young (2 patents)Eric LaCasse ↔ Jonathan P Durkin (1 patent)Eric LaCasseEric LaCasse (6 patents)Daniel McManusDaniel McManus (4 patents)Jon P DurkinJon P Durkin (7 patents)Robert G KornelukRobert G Korneluk (30 patents)Stephen BairdStephen Baird (14 patents)Martin HolcikMartin Holcik (6 patents)Sean YoungSean Young (2 patents)Jonathan P DurkinJonathan P Durkin (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Aegera Therapeutics, Inc. (4 from 24 patents)

2. University of Ottawa (1 from 163 patents)

3. Pharmascience Inc. (1 from 22 patents)


6 patents:

1. 8012944 - Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent

2. 7638497 - Antisense IAP nucleobase oligomers and uses thereof

3. 7638620 - Antisense IAP nucleobase oligomers and uses thereof

4. 7294713 - Antisense IAP oligonucleotides and uses thereof

5. 7091333 - Antisense IAP nucleobase oligomers and uses thereof

6. 6673917 - Antisense IAP nucleic acids and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…